Cvs Pharmacy #08802 Durable Medical Equipment & Medical Supplies Location: 131 W Riverside Dr, Parker, Arizona 85344 Phone: (928) 669-1092 |
Walmart Pharmacy 10-4543 Durable Medical Equipment & Medical Supplies Location: 100 W Riverside Dr, Parker, Arizona 85344 Phone: (928) 669-8306 |
Parker Vision Care Medicare Supplier Location: 115 W Riverside Dr, Parker, Arizona 85344 Phone: (928) 669-4297 |
News Archive
Surgeon Teresa Rutledge, MD, recently received the National Cancer Institute's Cancer Clinical Investigator Team Leadership Award. Only 11 people nationwide received the award this year. Dr. Rutledge is the third faculty member in the history of the University of New Mexico Cancer Center to be recognized with this honor.
The U.S. Food and Drug Administration today approved Botox injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.
Primary care physicians agree they have a role in addressing obesity, but say they do not have the right weight management resources. Obese or heavier adults take responsibility for weight loss, but adults who need to lose weight may lack information about effective weight loss methods and strategies. These findings and others come from new research commissioned and released today by the Strategies to Overcome and Prevent Obesity Alliance.
The Ministry of Health in Viet Nam has informed the World Health Organization (WHO) that three recent deaths from influenza-like illness in Viet Nam were caused by infection with avian influenza. These are the first officially reported cases of avian influenza in Viet Nam since late February.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the recent decision by the U.S. Food and Drug Administration (FDA) to grant approval of AstraZeneca's Seroquel XR for adjunctive treatment of major depressive disorder will not change Decision Resources' market forecast for the indication. As previously forecasted, Seroquel and Seroquel XR will garner nearly one quarter of antipsychotics sales as adjunctive treatments for major depressive disorder in 2013 in the world's major pharmaceutical markets.
› Verified 3 days ago